Breaking News
Get 45% Off 0
Selloff or market correction? Either way, here's what to do next
See Overvalued Stocks

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Innospec (IOSP) Up 27% In 3 Months: What's Driving It? By Zacks Investment Research - Nov 22, 2017

Shares of Innospec Inc. (NASDAQ:IOSP) have gained around 27% over the last three months. The company has also outperformed its industry’s gain of roughly 12% over the same time frame. ...

Zacks Investment Research
Here's Why H&E Equipment (HEES) Is A Solid Investment Choice By Zacks Investment Research - Nov 22, 2017

We believe that H&E Equipment Services, Inc. (NASDAQ:HEES) is a solid choice for investors seeking exposure to the machinery space. The company is poised to gain traction from its initiatives to...

Zacks Investment Research
Will A 'Huge Tax Cut' Ease Burden For MedTech Players? By Zacks Investment Research - Nov 22, 2017

After months of discussions, House Republicans has finally passed the much-controversial $1.5-trillion tax-reform bill by a vote of 227 to 205 on Nov 16. The members of the Senate Finance Committee...

Zacks Investment Research
Alliance Data's LoyaltyOne Inks Deal To Boost Client Service By Zacks Investment Research - Nov 22, 2017

Precima, part of Alliance Data Systems Corporation’s (NYSE:ADS) LoyaltyOne business, recently inked a new long-term agreement with Loblaw Companies Limited. The deal will help Alliance Data to...

Zacks Investment Research
Can Health Insurers Continue To Look Past ACA Threats In Q4? By Zacks Investment Research - Nov 22, 2017

President Donald Trump’s plans to repeal and replace the Affordable Care Act (ACA) or Obamacare have created quite an uproar among health insurers. ACA has been contributing significantly to...

Zacks Investment Research
Puma Inks License Deal To Commercialize Cancer Drug Nerlynx By Zacks Investment Research - Nov 22, 2017

Puma Biotechnology, Inc. (NASDAQ:PBYI) announced that it has inked an exclusive licensing agreement with Specialised Therapeutics Asia, a Singapore based biopharmaceutical company, to commercialize...

Zacks Investment Research
Hewlett Packard (HPE) CEO Whitman To Step Down, Shares Drop By Zacks Investment Research - Nov 22, 2017

In a sudden move, Meg Whitman has decided to step down as the Chief Executive Officer (CEO) of Hewlett Packard Enterprise Company (NYSE:HPE) , leaving the company in the middle of its restructuring...

Zacks Investment Research
Here's Why Washington Federal (WAFD) Stock Is A Must Buy Now By Zacks Investment Research - Nov 22, 2017

A favorable operating backdrop with the anticipation of another interest rate hike by the Fed has driven investors’ optimism on banking stocks. Therefore, some of these stocks are profitable...

Zacks Investment Research
Here's Why You Should Invest In Align Technology (ALGN) Now By Zacks Investment Research - Nov 22, 2017

Align Technology, Inc. (NASDAQ:ALGN) has been gaining investors’ confidence on consistent positive results. Over the past three months, the company’s share price has outperformed the...

Zacks Investment Research
Verizon (VZ) Gears Up For Black Friday Rush, Announces Offers By Zacks Investment Research - Nov 22, 2017

Per a recent FierceTelecom report, Verizon Communications Inc (NYSE:VZ) has come up with a range of wireline and wireless offers for Thanksgiving shoppers.Currently, Verizon carries a Zacks Rank #3...

Petros Steriotis
DAX Technicals: Nov 22 By Petros Steriotis - Nov 22, 2017

DAX looks good as long as 12,950-12,850 holds. source: Investing.com

Continue with Apple
Continue with Google
or
Sign up with Email